ArticleBMC medicine2024

Mesothelin- and nucleolin-specific T cells from combined short peptides effectively kill triple-negative breast cancer cells.

Suyanee Thongchot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.